History of IgA Nephropathy Mouse Models

History of IgA Nephropathy Mouse Models

IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world. It was first described in 1968 by Jean Berger and Nicole Hinglais as the presence of intercapillary deposits of IgA. Despite this simple description, patients with IgAN may present very broad clinical features ranging...

Full description

Bibliographic Details
Main Authors:	Batoul Wehbi, Virginie Pascal, Lina Zawil, Michel Cogné, Jean-Claude Aldigier
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Journal of Clinical Medicine
Subjects:	IgA nephropathy IgA kidney mesangium mouse model
Online Access:	https://www.mdpi.com/2077-0383/10/14/3142

Similar Items

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
by: Sheng Chang, et al.
Published: (2020-03-01)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
by: Yukako Ohyama, et al.
Published: (2021-08-01)

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01)

Predictors of prognosis in IgA nephropathy
by: Yasuhiko Tomino
Published: (2012-10-01)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
by: Pei Chen, et al.
Published: (2018-10-01)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
by: Yusuke Fukao, et al.
Published: (2022-06-01)

Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
by: Yan Lv, et al.
Published: (2023-08-01)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2017-11-01)

The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review
by: Hareem Farooq, MBBS, et al.
Published: (2022-02-01)

An Update on Current Therapeutic Options in IgA Nephropathy
by: Regina Shaoying Lim, et al.
Published: (2024-02-01)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
by: Haresh Selvaskandan, et al.
Published: (2020-10-01)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
by: Yan-feng Zhao, et al.
Published: (2017-09-01)

Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis
by: Yinhong Wang, et al.
Published: (2024-01-01)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
by: Renato C. Monteiro, et al.
Published: (2022-03-01)

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
by: Soumita Bagchi, et al.
Published: (2021-06-01)

Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
by: Sigridur Elíasdóttir, et al.
Published: (2023-06-01)

Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system
by: C Wang, et al.
Published: (2011-12-01)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01)

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation
by: Dita Maixnerova, et al.
Published: (2021-09-01)

Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials
by: Zheng Zhang, et al.
Published: (2019-08-01)

The clinical and pathological characteristics of IgA nephropathy patients in Tibet
by: Fenglei Si, et al.
Published: (2022-07-01)

IgA nephropathy in Kerala, India: A retrospective study
by: Chandrika B
Published: (2009-01-01)

Cyclosporine A combined with medium/low dose prednisone in progressive IgA nephropathy
by: Lin Xu, et al.
Published: (2014-08-01)

Proliferation and Cytokine Production of Human Mesangial Cells Stimulated by Secretory IgA Isolated from Patients with IgA Nephropathy
by: Yan Liang, et al.
Published: (2015-07-01)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patients
by: Yen-Ling Chiu, et al.
Published: (2021-06-01)

The Usefulness of Vanin-1 and Periostin as Markers of an Active Autoimmune Process or Renal Fibrosis in Children with IgA Nephropathy and IgA Vasculitis with Nephritis—A Pilot Study
by: Małgorzata Mizerska-Wasiak, et al.
Published: (2022-02-01)

Mitofusin2 expression is associated with podocyte injury in IgA nephropathy
by: Xuanli Tang, et al.
Published: (2023-03-01)

Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway
by: Wencheng Xu, et al.
Published: (2023-06-01)

Role of telitacicept in the treatment of IgA nephropathy
by: Lijun Wu, et al.
Published: (2023-09-01)

Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022-05-01)

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
by: Katerina Zachova, et al.
Published: (2020-02-01)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
by: Isabella Quinti, et al.
Published: (2021-04-01)

Plasmaphresis therapy for pulmonary hemorrhage in a pediatric patient with IgA nephropathy
by: Dae-Kyoon Yim, et al.
Published: (2015-10-01)

Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation
by: Mayuko Kawabe, et al.
Published: (2020-09-01)

The coincidence of IgA nephropathy and Fabry disease
by: Maixnerová Dita, et al.
Published: (2013-01-01)